Assessment of time to return of spontaneous ventilation after administration of either suxamethonium or rocuronium followed by sugammadex in patients undergoing planned surgery.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: i) ASA class I-III ii) Patients able to give written informed consent iii) Patients requiring general anaesthesia iv) Patients aged 18 – 65 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: i) History of dementia or difficulty in providing informed consent ii) Patients with chronic obstructive pulmonary disease (COPD) iii) Patients with a history of ischaemic heart disease (IHD) iv) Patients with a haemoglobin concentration of less than 10g dl-1 v) Patients with a history of known difficulty in intubation or with an anticipated challenging airway vi) Pregnancy vii) Patients with a history of allergy to any of the medications used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Length of time to resumption of spontaneous ventilation as indicated by visible diaphragmatic movement or decrease in oxygen saturation to = 90% before onset of spontaneous ventilation;Secondary Objective: (i) Frequency of desaturation to = 90% (ii) Length of time to movement of reservoir bag (iii) Length of time to first capnographic evidence of ventilation (iv) Incidence of adverse events in all groups ;Primary end point(s): The primary end point is the time to resumption of spontaneous ventilation after administration of suxamethonium or rocuronium followed by sugammadex. | — |
Countries
United Kingdom